Synthesis of clay-templated subnano-sized zero valent iron (ZVI) particles and clays containing same
    1.
    发明授权
    Synthesis of clay-templated subnano-sized zero valent iron (ZVI) particles and clays containing same 有权
    粘土模板亚纳米零价铁(ZVI)颗粒和含有它们的粘土的合成

    公开(公告)号:US08633133B2

    公开(公告)日:2014-01-21

    申请号:US12915428

    申请日:2010-10-29

    IPC分类号: B01J20/00

    摘要: A clay comprising a 2:1 aluminosilicate clay having negative charge sites, the 2:1 aluminosilicate clay containing subnano-sized zero valent iron (ZVI) particles distributed on clay surfaces is provided. In one embodiment, at least some or all of the particles have a cross-section of five (5) angstroms or less. Methods of synthesizing and the novel clays and the clay-templated subnano-scale ZVI particles themselves are also described. Such novel products are useful in a variety of remediation applications, including for reduction and dechlorination reactions.

    摘要翻译: 提供了一种包含具有负电荷位点的2:1铝硅酸盐粘土的粘土,提供了分布在粘土表面上的含有亚纳米级零价铁(ZVI)颗粒的2:1铝硅酸盐粘土。 在一个实施方案中,至少一些或全部颗粒具有五(5)埃或更小的横截面。 还描述了合成方法和新型粘土和粘土模板亚纳米级ZVI颗粒本身。 这些新产品可用于各种补救应用,包括还原和脱氯反应。

    HIV-1 INHIBITING PHARMACEUTICAL COMPOSITION CONTAINING AN ECKLONIA CAVA-DERIVED PHLOROGLUCINOL POLYMER COMPOUND
    2.
    发明申请
    HIV-1 INHIBITING PHARMACEUTICAL COMPOSITION CONTAINING AN ECKLONIA CAVA-DERIVED PHLOROGLUCINOL POLYMER COMPOUND 审中-公开
    含有ECKLONIA CAVA衍生的PHLOROGLUCINOL聚合物化合物的HIV-1抑制药物组合物

    公开(公告)号:US20130338218A1

    公开(公告)日:2013-12-19

    申请号:US13964687

    申请日:2013-08-12

    IPC分类号: C07D319/24

    摘要: The present invention relates to a HIV-1 inhibiting pharmaceutical composition containing, as an active ingredient, 6,6′-bieckol which is a phloroglucinol polymer compound separated from Ecklonia cava. The Ecklonia cava-derived 6,6′-bieckol according to the present invention inhibits HIV-1 induced cell fusion, the cell lysis effect, and the cytopathogenic effect including virus p24 antibody production, exhibits RT enzyme inhibition activity and HIV-1 infection inhibition activity, and shows no cytotoxicity at the concentration that almost perfectly inhibits HIC-1 replication.

    摘要翻译: 本发明涉及一种HIV-1抑制药物组合物,其含有作为活性成分的6,6'-双酚,其为从Ecklonia cava分离的间苯三酚聚合物化合物。 根据本发明的Ecklonia Cava衍生的6,6'-双卡洛酮抑制HIV-1诱导的细胞融合,细胞裂解作用和细胞病变效应,包括病毒p24抗体产生,表现出RT酶抑制活性和HIV-1感染抑制 活性,并且在几乎完全抑制HIC-1复制的浓度下不显示细胞毒性。